Palvella Therapeutics, Inc.
PVLA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$11,345 | -$9,471 | -$8,185 | -$3,951 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $1,433 | $0 | $268 |
| Change in WC | $0 | $1,132 | -$967 | -$3,596 |
| Other Non-Cash | $11,345 | $1,472 | $2,384 | $1,886 |
| Operating Cash Flow | $0 | -$5,434 | -$6,768 | -$5,393 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $6,000 |
| Stock Issued | $0 | $349 | $67 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$1,269 | $68,785 |
| Financing Cash Flow | $0 | $349 | -$1,202 | $74,785 |
| Forex Effect | -$6,866 | -$108 | $64,233 | $3 |
| Net Chg. in Cash | -$6,866 | -$5,193 | $56,263 | $69,395 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $70,433 | $75,626 | $19,363 | $14,207 |
| End Cash | $63,567 | $70,433 | $75,626 | $83,602 |
| Free Cash Flow | $0 | -$5,434 | -$6,768 | -$5,393 |